Diabetes treatment tech company Bigfoot Biomedical announced today that it raised $55 million to close its Series C financing round. Abbott (NYSE:ABT) led the funding round with participation from new investor Smile Group and existing investors Quadrant ...
from Google Alert - health https://ift.tt/3cwKswN
via IFTTT
0 comments:
Post a Comment